米国の腰再建市場：規模、動向、予測（2021-2025年版）

米国の腰再建市場：規模、動向、予測（2021-2025年版）
The US Hip Reconstruction Market: Size, Trends and Forecasts (2021-2025 Edition)

このレポートへお問合せ

レポート目次

Report Details

Scope of the Report

The report titled “The US Hip Reconstruction Market: Size, Trends and Forecasts (2021-2025 Edition)”, provides an in depth analysis of the US hip reconstruction market by value, by procedure volume, by type, etc. The report also provides a detailed analysis of the US primary total hip reconstruction market by value, and by type.

The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the US hip reconstruction market has also been forecasted for the period 2021-2025, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.

The hip reconstruction market is dominated by few players, but there are other new players, private label players as well. However, the competition in the US hip reconstruction market is dominated by Zimmer Biomet Holdings, Inc., Johnson & Johnson, Stryker Corporation and Smith & Nephew Plc, who are also profiled with their financial information and respective business strategies.

Company Coverage

Zimmer Biomet Holdings Inc.
Johnson & Johnson
Stryker Corporation
Smith & Nephew Plc

Executive Summary

The hip reconstruction market can be segmented on the basis of type. There are four major types of hip reconstruction procedures: Primary Total Hip Reconstruction, Partial Hip Reconstruction, Hip Resurfacing and Revision Hip Reconstruction. Primary Total Hip Reconstruction is further segmented into three types: Cemented Hip Reconstruction, Cementless Hip Reconstruction and Hybrid Hip Reconstruction.

The US hip reconstruction market has increased at a significant CAGR over the years and projections are made that the market would rise in the next four years i.e. 2021-2025 tremendously. The hip reconstruction market is expected to increase due to aging population, growing prevalence of arthritis, increasing obesity, growth in chronic diseases, escalating healthcare expenditure, etc. Yet the market faces some challenges such as high cost involved, regulatory risk, etc.

Table of Contents

1. Executive Summary

2. Introduction

2.1 Orthopedic Surgery: An Overview
2.1.1 Types of Orthopedic Surgery

2.2 Hip Reconstruction: An Overview
2.2.1 Symptoms for Hip Reconstruction
2.2.2 Indications for Hip Reconstruction
2.2.3 Risks Associated with Hip Reconstruction Surgery

2.3 Hip Reconstruction Segmentation: An Overview
2.3.1 Hip Reconstruction Segmentation by Type
2.3.2 Hip Reconstruction Segmentation by End-users

3. Global Market Analysis

3.1 Global Hip Reconstruction Market: An Analysis

3.1.1 Global Hip Reconstruction Market by Value
3.1.2 Global Hip Reconstruction Market by Procedure Volume
3.1.3 Global Hip Reconstruction Market Value by Region (The US, Europe & Rest of the World)
3.1.4 Global Hip Reconstruction Procedure Volume by Region (The US, Germany, France, UK, Italy & Spain)

4. The US Market Analysis

4.1 The US Hip Reconstruction Market: An Analysis

4.1.1 The US Hip Reconstruction Market by Value
4.1.2 The US Hip Reconstruction Market by Procedure Volume
4.1.3 The US Hip Reconstruction Market Value by Type (Primary Total Hip Reconstruction, Partial Hip Reconstruction, Revision Hip Reconstruction & Hip Resurfacing)
4.1.4 The US Hip Reconstruction Procedure Volume by Type (Primary Total Hip Reconstruction, Partial Hip Reconstruction, Revision Hip Reconstruction & Hip Resurfacing)

4.2 The US Hip Reconstruction Market: Type Analysis

4.2.1 The US Primary Total Hip Reconstruction Market by Value
4.2.2 The US Primary Total Hip Reconstruction Market by Procedure Volume
4.2.3 The US Primary Total Hip Reconstruction Market by Type (Cementless, Hybrid & Cemented)
4.2.4 The US Primary Total Hip Reconstruction Procedure Volume by Type (Cementless, Hybrid & Cemented)
4.2.5 The US Cemented Primary Total Hip Reconstruction Market by Value
4.2.6 The US Cemented Primary Total Hip Reconstruction Market by Procedure Volume
4.2.7 The US Cementless Primary Total Hip Reconstruction Market by Value
4.2.8 The US Cementless Primary Total Hip Reconstruction Market by Procedure Volume
4.2.9 The US Hybrid Primary Total Hip Reconstruction Market by Value
4.2.10 The US Hybrid Primary Total Hip Reconstruction Market by Procedure Volume
4.2.11 The US Partial Hip Reconstruction Market by Value
4.2.12 The US Partial Hip Reconstruction Market by Procedure Volume
4.2.13 The US Revision Hip Reconstruction Market by Value
4.2.14 The US Revision Hip Reconstruction Market by Procedure Volume
4.2.15 The US Hip Resurfacing Market by Value
4.2.16 The US Hip Resurfacing Market by Procedure Volume

5. Market Dynamics

5.1 Growth Driver
5.1.1 Aging Population
5.1.2 Rise in Urban Population
5.1.3 Growing Prevalence of Arthritis
5.1.4 Increasing Obesity
5.1.5 Growth in Chronic Diseases
5.1.6 Escalating Healthcare Expenditure

5.2 Challenges
5.2.1 Shortage of Orthopedic Surgeons
5.2.2 High Cost Involved
5.2.3 In-surgery and Post-Surgery Complications
5.2.4 Regulatory Risk

5.3 Market Trends
5.3.1 Increasing Acceptance of Minimally Invasive Hip Reconstructions
5.3.2 Rising Preference for Reverse Hybrid Hip Reconstructions
5.3.3 Growing Popularity of Hip Resurfacing

6. Competitive Landscape

6.1 The US Hip Reconstruction Market Players: A Financial Comparison
6.2 The US Hip Reconstruction Players by Market Share

7. Company Profiles

7.1 Zimmer Biomet Holdings, Inc.
7.1.1 Business Overview
7.1.2 Financial Overview
7.1.3 Business Strategy

7.2 Johnson & Johnson
7.2.1 Business Overview
7.2.2 Financial Overview
7.2.3 Business Strategy

7.3 Stryker Corporation
7.3.1 Business Overview
7.3.2 Financial Overview
7.3.3 Business Strategy

7.4 Smith & Nephew Plc
7.4.1 Business Overview
7.4.2 Financial Overview
7.4.3 Business Strategy

List of Figures

Figure 1: Types of Orthopedic Surgery
Figure 2: Symptoms for Hip Reconstruction
Figure 3: Indications for Hip Reconstruction
Figure 4: Risks Associated with Hip Reconstruction Surgery
Figure 5: Hip Reconstruction Segmentation by Type
Figure 6: Hip Reconstruction Segmentation by End-users
Figure 7: Global Hip Reconstruction Market by Value; 2016-2020 (US$ Billion)
Figure 8: Global Hip Reconstruction Market by Value; 2021-2025 (US$ Billion)
Figure 9: Global Hip Reconstruction Market by Procedure Volume; 2016-2020 (Million)
Figure 10: Global Hip Reconstruction Market by Procedure Volume; 2021-2025 (Million)
Figure 11: Global Hip Reconstruction Market Value by Region; 2020 (Percentage, %)
Figure 12: Global Hip Reconstruction Procedure Volume by Region; 2020 (Percentage, %)
Figure 13: The US Hip Reconstruction Market by Value; 2016-2020 (US$ Billion)
Figure 14: The US Hip Reconstruction Market by Value; 2021-2025 (US$ Billion)
Figure 15: The US Hip Reconstruction Market by Procedure Volume; 2016-2020 (Thousand)
Figure 16: The US Hip Reconstruction Market by Procedure Volume; 2021-2025 (Thousand)
Figure 17: The US Hip Reconstruction Market Value by Type; 2020 (Percentage, %)
Figure 18: The US Hip Reconstruction Procedure Volume by Type; 2020 (Percentage, %)
Figure 19: The US Primary Total Hip Reconstruction Market by Value; 2016-2020 (US$ Billion)
Figure 20: The US Primary Total Hip Reconstruction Market by Value; 2021-2025 (US$ Billion)
Figure 21: The US Primary Total Hip Reconstruction Market by Procedure Volume;2016-2020 (Thousand)
Figure 22: The US Primary Total Hip Reconstruction Market by Procedure Volume;2021-2025 (Thousand)
Figure 23: The US Primary Total Hip Reconstruction Market by Type; 2020 (Percentage, %)
Figure 24: The US Primary Total Hip Reconstruction Procedure Volume by Type; 2020 (Percentage, %)
Figure 25: The US Cemented Primary Total Hip Reconstruction Market by Value; 2016-2020 (US$ Million)
Figure 26: The US Cemented Primary Total Hip Reconstruction Market by Value; 2021-2025 (US$ Million)
Figure 27: The US Cemented Primary Total Hip Reconstruction Market by Procedure Volume; 2016-2020 (Thousand)
Figure 28: The US Cemented Primary Total Hip Reconstruction Market by Procedure Volume; 2021-2025 (Thousand)
Figure 29: The US Cementless Primary Total Hip Reconstruction Market by Value; 2016-2020 (US$ Billion)
Figure 30: The US Cementless Primary Total Hip Reconstruction Market by Value; 2021-2025 (US$ Billion)
Figure 31: The US Cementless Primary Total Hip Reconstruction Market by Procedure Volume; 2016-2020 (Thousand)
Figure 32: The US Cementless Primary Total Hip Reconstruction Market by Procedure Volume; 2021-2025 (Thousand)
Figure 33: The US Hybrid Primary Total Hip Reconstruction Market by Value; 2016-2020 (US$ Million)
Figure 34: The US Hybrid Primary Total Hip Reconstruction Market by Value; 2021-2025 (US$ Million)
Figure 35: The US Hybrid Primary Total Hip Reconstruction Market by Procedure Volume;2016-2020 (Thousand)
Figure 36: The US Hybrid Primary Total Hip Reconstruction Market by Procedure Volume;2021-2025 (Thousand)
Figure 37: The US Partial Hip Reconstruction Market by Value; 2016-2020 (US$ Million)
Figure 38: The US Partial Hip Reconstruction Market by Value; 2021-2025 (US$ Million)
Figure 39: The US Partial Hip Reconstruction Market by Procedure Volume; 2016-2020 (Thousand)
Figure 40: The US Partial Hip Reconstruction Market by Procedure Volume; 2021-2025 (Thousand)
Figure 41: The US Revision Hip Reconstruction Market by Value; 2016-2020 (US$ Million)
Figure 42: The US Revision Hip Reconstruction Market by Value; 2021-2025 (US$ Million)
Figure 43: The US Revision Hip Reconstruction Market by Procedure Volume; 2016-2020 (Thousand)
Figure 44: The US Revision Hip Reconstruction Market by Procedure Volume; 2021-2025 (Thousand)
Figure 45: The US Hip Resurfacing Market by Value; 2016-2020 (US$ Million)
Figure 46: The US Hip Resurfacing Market by Value; 2021-2025 (US$ Million)
Figure 47: The US Hip Resurfacing Market by Procedure Volume; 2016-2020 (Thousand)
Figure 48: The US Hip Resurfacing Market by Procedure Volume; 2021-2025 (Thousand)
Figure 49: The US Aging Population; 2010-2050 (Percentage, %)
Figure 50: The US Urban Population; 2015-2020 (Million)
Figure 51: The US Arthritis Population; 2010-2040 (Million)
Figure 52: The US Symptomatic Hip Osteoarthritis Patients; 2015-2020 (Thousand)
Figure 53: The US Obesity Rates; 2015-2030 (Percentage, %)
Figure 54: The US Chronic Diseases Growth Rate; 2016-2025 (Percentage, %)
Figure 55: The US Healthcare Expenditure; 2012-2024 (US$ Trillion)
Figure 56: The US Hip Reconstruction Players by Market Share; 2019-2020 (Percentage, %)
Figure 57: Zimmer Biomet Holdings, Inc. Net Sales; 2016-2020 (US$ Billion)
Figure 58: Zimmer Biomet Holdings, Inc. Net Sales by Product; 2020 (Percentage, %)
Figure 59: Zimmer Biomet Holdings, Inc. Net Sales by Region; 2020 (Percentage, %)
Figure 60: Johnson & Johnson Sales; 2016-2020 (US$ Billion)
Figure 61: Johnson & Johnson Sales by Segments; 2020 (Percentage, %)
Figure 62: Johnson & Johnson Sales by Region; 2020 (Percentage, %)
Figure 63: Stryker Corporation Net Sales; 2016-2020 (US$ Billion)
Figure 64: Stryker Corporation Net Sales by Segments; 2020 (Percentage, %)
Figure 65: Stryker Corporation Net Sales by Region; 2020 (Percentage, %)
Figure 66: Smith & Nephew Plc Revenue; 2016-2020 (US$ Billion)
Figure 67: Smith & Nephew Plc Revenue by Products; 2020 (Percentage, %)
Figure 68: Smith & Nephew Plc Revenue by Region; 2020 (Percentage, %)
Table 1: The US Hip Reconstruction Market Players: A Financial Comparison; 2020

お問合せフォーム

プライバシーポリシーはこちらをご覧ください。